Dr Clyde Frederick Hollon, MD | |
801 W 5th Ave, Suite 518, Spokane, WA 99204-2823 | |
(509) 747-3147 | |
(509) 747-0020 |
Full Name | Dr Clyde Frederick Hollon |
---|---|
Gender | Male |
Speciality | Urology |
Location | 801 W 5th Ave, Spokane, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669589388 | NPI | - | NPPES |
14965 | Other | WA | L& I NUMBER |
8249906 | Medicaid | WA | |
340011680 | Other | WA | RRB |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD000131151 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Clyde Frederick Hollon, MD 5447 S Quail Ridge Cir, Spokane, WA 99223-6390 Ph: (509) 443-1183 | Dr Clyde Frederick Hollon, MD 801 W 5th Ave, Suite 518, Spokane, WA 99204-2823 Ph: (509) 747-3147 |
News Archive
With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.
These enzymes are integrated into a single molecular complex known as fatty acid synthase. This complex is regarded as a potential target for developing new anti-obesity and anti-cancer drugs.
Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.
KAEL-GemVax, a leading oncology biopharmaceutical company, today announced that it had been officially notified by the independent Data Monitoring Committee that over 1000 patients have been enrolled in the TeloVac Study, making it the world's largest ever pancreatic cancer vaccine trial.
› Verified 6 days ago
Dr. Jonathan Frank Kalisvaart, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Suite 100, Spokane, WA 99204 Phone: 509-624-3126 Fax: 509-227-7070 | |
Michelle A Gupta, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 100, Spokane, WA 99204 Phone: 509-474-5489 Fax: 509-227-7070 | |
Dr. Carl J Walker, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 E Trent Ave # 200, Spokane, WA 99202 Phone: 509-747-3147 | |
Evan Carlos, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 E Trent Ave # 200, Spokane, WA 99202 Phone: 509-747-3147 | |
Duncan Sloan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 E Trent Ave # 200, Spokane, WA 99202 Phone: 509-747-3147 | |
Dr. Thomas N Fairchild, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 820 S Mcclellan St, Suite 118, Spokane, WA 99204 Phone: 509-747-3147 Fax: 509-747-0020 | |
Dr. Bryan B Voelzke, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 E Trent Ave Ste 200, Spokane, WA 99202 Phone: 509-747-3147 |